Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study

A COVID-19 booster vaccination is being comprehensively evaluated globally due to the emerging concern of reduced protection rate of previous vaccination and circulating Variants of Concern (VOC). But the safety and immunogenicity of homologous BBIBP-CorV boosting vaccination are yet to be thoroughl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ai, Jingwen, Zhang, Yi, Zhang, Haocheng, Zhang, Qiran, Fu, Zhangfan, Lin, Ke, Song, Jieyu, Zhao, Yuanhan, Fan, Mingxiang, Wang, Hongyu, Zhou, Yang, Chen, Xiaohua, Qiu, Chao, Zhang, Wenhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881062/
https://www.ncbi.nlm.nih.gov/pubmed/35034582
http://dx.doi.org/10.1080/22221751.2022.2025746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881062/
https://www.ncbi.nlm.nih.gov/pubmed/35034582
http://dx.doi.org/10.1080/22221751.2022.2025746

Ejemplares similares